Guillaume BIDAULT

Guillaume BIDAULT

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
GBGuillaume BIDAULT
Guillaume BIDAULT
SVSamuel Virtue
Samuel Virtue
KPKasparas Petkevicius
Kasparas Petkevicius
HJHelen E. Jolin
Helen E. Jolin
ADAurélien Dugourd
Aurélien Dugourd
AVAntonio Vidal-Puig
Antonio Vidal-Puig

12 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
GBGuillaume BIDAULT
Guillaume BIDAULT
MGMarie Garcia
Marie Garcia
JCJacqueline Capeau
Jacqueline Capeau
RMRomain Morichon
Romain Morichon
CVCorinne Vigouroux
Corinne Vigouroux
VBVéronique BEREZIAT
Véronique BEREZIAT
Hutchinson–Gilford progeria syndrome (HGPS) is a rare premature aging disorder notably characterized by precocious and deadly atherosclerosis. Almost 90% of HGPS patients carry a LMNA p.G608G splice variant that leads to the expression of a permanently farnesylated abnormal form of prelamin-A, referred to as progerin. Endothelial dysfunction is a key determinant of atherosclerosis, notably during aging. Previous studies have shown that progerin accumulates in HGPS patients’ endothelial cells but also during vascular physiological aging. However, whether progerin expression in human endothelial cells can recapitulate features of endothelial dysfunction is currently unknown. Herein, we evaluated the direct impact of exogenously expressed progerin and wild-type lamin-A on human endothelial cell function and senescence. Our data demonstrate that progerin, but not wild-type lamin-A, overexpression induces endothelial cell dysfunction, characterized by increased inflammation and oxidative stress together with persistent DNA damage, increased cell cycle arrest protein expression and cellular senescence. Inhibition of progerin prenylation using a pravastatin–zoledronate combination partly prevents these defects. Our data suggest a direct proatherogenic role of progerin in human endothelial cells, which could contribute to HGPS-associated early atherosclerosis and also potentially be involved in physiological endothelial aging participating to age-related cardiometabolic diseases.

25 April 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
VPV. Pellegrinelli
V. Pellegrinelli
SRS. Rodriguez-Cuenca
S. Rodriguez-Cuenca
CRC. Rouault
C. Rouault
EFElizabeth Figueroa-Juarez
Elizabeth Figueroa-Juarez
Hanna Marie SchilbertHanna Marie Schilbert
Hanna Marie Schilbert
AVAntonio Vidal-Puig
Antonio Vidal-Puig

8 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
KPKasparas Petkevicius
Kasparas Petkevicius
SVSamuel Virtue
Samuel Virtue
GBGuillaume BIDAULT
Guillaume BIDAULT
BJBenjamin Jenkins
Benjamin Jenkins
CCCankut Cubuk
Cankut Cubuk
AVAntonio Vidal-Puig
Antonio Vidal-Puig
White adipose tissue (WAT) inflammation contributes to the development of insulin resistance in obesity. While the role of adipose tissue macrophage (ATM) pro-inflammatory signalling in the development of insulin resistance has been established, it is less clear how WAT inflammation is initiated. Here, we show that ATMs from obese mice and humans exhibit markers of increased de novo phosphatidylcholine (PC) biosynthesis rate. Macrophage-specific knockout of phosphocholine-cytidylyltransferase A (CCTα), the rate-limiting enzyme of de novo PC biosynthesis pathway, alleviated obesity-induced WAT inflammation and insulin resistance. Mechanistically, CCTα-deficient macrophages showed reduced ER stress and inflammation in response to palmitate. Surprisingly, this was not due to lower exogenous palmitate incorporation into cellular PCs. Instead, CCTα-null macrophages had lower PC turnover, leading to elevated membrane polyunsaturated fatty acids that negated the pro-inflammatory effects of palmitate. Our results reveal a link between obesity-associated increase in PC synthesis, accelerated PC turnover and pro-inflammatory activation of ATMs.

10 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SPSatish Patel
Satish Patel
AHAfreen Haider
Afreen Haider
AAAnna Alvarez-Guaita
Anna Alvarez-Guaita
GBGuillaume BIDAULT
Guillaume BIDAULT
JMJulia Sarah El-Sayed Moustafa
Julia Sarah El-Sayed Moustafa
DSDavid B. Savage
David B. Savage
Summary: Obesity in mice and humans is associated with elevated levels of at least two hormones responsive to cellular stress, namely GDF15 and FGF21. Over-expression of each of these is associated with weight loss and beneficial metabolic changes but where they are secreted from and what they are required for physiologically in the context of overfeeding remains unclear. Here we used tissue selective knockout mouse models to establish that, like FGF21, circulating GDF15 is primarily derived from the liver, rather than adipose tissue, muscle or macrophages in high fat fed mice. Combined whole body deletion of FGF21 and GDF15 does not result in any additional weight gain in high fat fed mice but is associated with significantly greater hepatic steatosis and insulin resistance. Collectively the data suggest that activation of the integrated stress response in hepatocytes is a major driver for GDF15 and FGF21 secretion in the context of overfeeding, and that they both act to alleviate this metabolic stress.

8 May 2026 in Science Advances
Verified
Journal Article
Open access
XDXiaowen Duan
Xiaowen Duan
LDLucy M. Davis
Lucy M. Davis
SPSatish Patel
Satish Patel
GBGuillaume BIDAULT
Guillaume BIDAULT
LLLu Long
Lu Long
DSDavid B. Savage
David B. Savage
Insulin resistance (IR) links obesity to metabolic disorders. While weight loss reverses IR, we show that calorie reduction (CR) can do so in obese mice within a day before significant weight loss. In contrast to whole-body IR, individual tissues do not revert to their original chow diet–fed states after CR. In the liver, improved insulin sensitivity correlates with reduced triacylglycerol and diacylglycerol and protein kinase C epsilon activity, alongside substantially decreased de novo lipogenesis and increased ketones. In muscle, insulin-sensitive glucose disposal was restored, whereas obesity-associated adipose tissue changes largely persisted following CR, specifically the reduction in fasting lipolytic activity mediated at least, in part, by lower β-adrenergic receptor 3 expression. This, combined with enhanced oxidative pathways in muscle and liver, resulted in lowered plasma free fatty acid levels and muscle and liver lipids, facilitating insulin-stimulated glucose disposal and thus restored insulin sensitivity.